Rapid Dose Therapeutics Corp. (CNSX: DOSE)
Health Care · Pharmaceuticals · CA
CA$0.10
-16.67% today · -44.4% 1Y
Rapid Dose Therapeutics Corp. (CNSX: DOSE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.57M and employs 12 people.
Over the last twelve months the share price has lost 44.4%, trading between 0.08 and 0.19.
Tweenvest scores Rapid Dose Therapeutics Corp. across four factors: quality 12/100, value 52/100, growth 100/100. Its strongest factor is growth.
DOSE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.57M
- Revenue (TTM)
- $1.87M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -0.85
- 52-week high
- CA$0.19
- 52-week low
- CA$0.08
- Avg volume (3M)
- —
- Shares outstanding
- 136.44M
- Employees
- 12
- Next earnings
- —
About Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company's flagship product is QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter medicines—directly into the bloodstream. They offer specific QuickStrip variants like QuickStrip energy for caffeine delivery, QuickStrip B12 for vitamin B12 supplementation, and QuickStrip sleep for melatonin. Beyond its proprietary products, the firm also delivers comprehensive services encompassing product innovation, manufacturing, and consultation to industries including nutraceuticals, cannabis healthcare, and pharmaceutical production. Rapid Dose Therapeutics maintains a significant research collaboration with McMaster University, focusing on crafting enhanced biopolymer compositions for oral dissolvable thin films and investigating an orally administered vaccine candidate for COVID-19.
- ISIN
- CA75339A1012
- Listed since
- Feb 10, 2010
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CalciMedica, Inc.NasdaqCM: CALC | $10.11M | $1.30 | -12.16% |
| Bio Essence CorporationOTCPK: BIOE | $9.79M | $— | — |
| Protect Pharmaceutical CorporationOTCPK: PRTT | $9.77M | $0.17 | +13.33% |
| Avicanna Inc.TSX: AVCN | $9.66M | CA$0.11 | +5.00% |
| S.C. Sintofarm S.A.BVB: SINT | $9.37M | RON— | — |
| Mercury Laboratories LimitedBSE: 538964 | $9.32M | Rs748.00 | -10.20% |
| Marinomed Biotech AGWBAG: MARI | $9.11M | €4.00 | -11.11% |
| Vilin Bio Med LimitedNSEI: VILINBIO | $8.99M | Rs56.50 | +9.71% |
Figures last refreshed Oct 4, 2026.